Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
A 2 arm study ( 1 Active, 1 Placebo) to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men
Age
45–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Symptoms of Overactive Bladder (OAB)
You may not be if
Current use of antimuscarinic therapy
Evidence of a urinary tract infection
Clareo Health | A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
